香港股市 將收市,收市時間:1 小時 36 分鐘

ASND Jun 2024 165.000 call

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
11.300.00 (0.00%)
市場開市。 截至 02:50PM EDT。
全螢幕
前收市價11.30
開市12.11
買盤0.00
賣出價5.00
拍板165.00
到期日2024-06-21
今日波幅11.30 - 12.11
合同範圍
成交量11
未平倉合約24
  • Insider Monkey

    Ascendis Pharma A/S (ASND) Stock Soared on Unexpected Demand

    TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter the fund returned 5.77% (net), compared to a 7.58% return for the Russell 2000 Growth Index. Despite a decline in many equity markets in […]

  • Benzinga

    FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months

    Tuesday, Ascendis Pharma A/S (NASDAQ:ASND) announced that the FDA extended the review date for TransCon PTH (palopegteriparatide) for adults with hypoparathyroidism. Hypoparathyroidism is an uncommon condition in which the body produces abnormally low levels of parathyroid hormone (PTH). The low production of PTH in hypoparathyroidism leads to abnormally low calcium levels in the blood and an increase of phosphorus in the blood. The agency said the information Ascendis Pharma submitted in respon

  • Zacks

    FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing

    Per the FDA, the data submitted by Ascendis (ASND) for its hormone replacement therapy constitutes a major amendment to its previously-submitted data. A final decision is expected by Aug 14.